Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	329.63	383.65	599.66	716.87	778.67	799.25
Revenue Growth (YoY)	-23.64%	-36.02%	-16.35%	-7.94%	-2.57%	4.71%
Cost of Revenue	244.27	283.13	437.91	487.58	492.89	486.26
Gross Profit	85.36	100.51	161.75	229.29	285.78	312.99
Selling, General & Admin	227.21	221.52	209.99	185.61	175.07	171.85
Other Operating Expenses	-	-	-	-1.1	-1.05	-0.94
Operating Expenses	227.21	221.52	209.99	184.51	174.02	170.91
Operating Income	-141.85	-121.01	-48.25	44.78	111.76	142.09
Interest Expense	-3.73	-4.48	-4.38	-3.61	-4.71	-2.78
Interest & Investment Income	3.24	5.34	5.17	9.45	9.67	12.05
Other Non Operating Income (Expenses)	0.58	0.58	0.96	-0.26	-0.05	-0.02
Pretax Income	-141.76	-119.58	-46.5	50.36	116.67	151.35
Income Tax Expense	12.42	13.37	17.99	17.29	14.41	31.49
Net Income	-154.19	-132.95	-64.48	33.08	102.26	119.85
Net Income to Common	-154.19	-132.95	-64.48	33.08	102.26	119.85
Net Income Growth	-	-	-	-67.65%	-14.68%	0.77%
Shares Outstanding (Basic)	137	137	137	137	137	137
Shares Outstanding (Diluted)	137	137	137	137	137	137
EPS (Basic)	-1.13	-0.97	-0.47	0.24	0.75	0.88
EPS (Diluted)	-1.13	-0.97	-0.47	0.24	0.75	0.88
EPS Growth	-	-	-	-67.65%	-14.68%	0.92%
Free Cash Flow	-13.93	6.49	-29.57	-16.7	-16.8	82.22
Free Cash Flow Per Share	-0.10	0.05	-0.22	-0.12	-0.12	0.60
Dividend Per Share	-	-	0.100	0.100	0.300	0.500
Dividend Growth	-	-	-	-66.67%	-40.00%	-
Gross Margin	25.90%	26.20%	26.97%	31.99%	36.70%	39.16%
Operating Margin	-43.03%	-31.54%	-8.05%	6.25%	14.35%	17.78%
Profit Margin	-46.78%	-34.65%	-10.75%	4.61%	13.13%	15.00%
Free Cash Flow Margin	-4.23%	1.69%	-4.93%	-2.33%	-2.16%	10.29%
EBITDA	-88.2	-63.18	10.54	107.29	174.33	207.38
EBITDA Margin	-26.76%	-16.47%	1.76%	14.97%	22.39%	25.95%
D&A For EBITDA	53.64	57.83	58.79	62.51	62.57	65.29
EBIT	-141.85	-121.01	-48.25	44.78	111.76	142.09
EBIT Margin	-43.03%	-31.54%	-8.05%	6.25%	14.35%	17.78%
Effective Tax Rate	-	-	-	34.33%	12.35%	20.81%
Advertising Expenses	-	5.37	3.82	3.81	5.92	20.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.